Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Is Cannabis Part of Any Current Treatment Protocol for Panic Disorder? 

Posted
Updated
ByMy Patient Advice
Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

The inclusion of cannabis in treatment protocols for panic disorder  is being explored as a potential complementary therapy. Evaluating clinical use, guideline inclusion, and therapeutic pathways helps clarify whether cannabis is formally recognised in current management strategies. Understanding cannabis in treatment protocols for panic guides clinicians and patients in making informed treatment decisions. 

Medical Cannabis UK

Integrating Cannabis into Care 

Professional review of cannabis treatment protocols for panic ensures that its application aligns with evidence-based practices and patient safety. 

Clinical Use 

Clinical use of cannabis is mostly experimental, with some practitioners considering it for symptom management under supervision, but standardisation is limited. 

Guideline Inclusion 

Current guideline inclusion remains minimal, as most professional recommendations for panic disorder do not formally endorse cannabis as a primary treatment. 

Therapeutic Pathways 

Exploring therapeutic pathways involves understanding how cannabis might complement behavioural therapies, pharmacological interventions, or other supportive strategies. 

In conclusion, cannabis treatment protocols for panic are emerging but not widely formalised. Considering clinical use, guideline inclusion, and therapeutic pathways helps patients and clinicians evaluate its potential role safely. 

If you’re exploring cannabis treatment options for panic disorder, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Panic Disorder . 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories